Partnering for a Better User Experience
DALI is open to partner for customized solutions and designs, from concept to commercialization.
Partnership opportunities are diverse, ranging from pharma companies (whether biological drugs, generics, or biosimilars) that want to differentiate and enhance their patients’ drug administration experience, to medical device companies that want to add solutions to their portfolios.
DALI can create a better user experience and increased compliance for patients. This is needed now more than ever, due to the trend of homecare treatment and the growth in the patient population requiring self-injection (e.g., diabetes, rheumatoid arthritis, multiple sclerosis, anemia, cancer, osteoporosis, hepatitis B and C, infertility, growth hormone disorders, and others).
E3D – Elcam Drug Delivery Devices
E3D (Elcam Drug Delivery Devices) and DALI have partnered for over 15 years. Elcam and DALI co-developed a variety of innovative drug delivery devices (such as different types of autoinjectors). Thanks to this extensive, long-lasting, and fruitful partnership, E3D and DALI have commercialized successful products.
Visit: https://www.elcam3d.com
Everads Therapy
In 2017, DALI’s co-founders, David and Lior, co-founded Everads Therapy together with the Rad-Biomed incubator and Sheba Tel Hashomer, City of Health. Everads Therapy is an Israeli startup that develops a novel system for effective suprachoroidal injection. The solution is based on the invention of Dr. Ygal Rotenstreich, Head of the Electrophysiology Clinic and Retinal Research Laboratory at Sheba Tel Hashomer, City of Health.
The Israel Innovation Authority
The Israel Innovation Authority, responsible for the Israeli innovation policy, operates for the benefit of the Israeli innovation ecosystem and the Israeli economy.
During the development of DALI’s SAN-L, the first developed product of the SAN Product Line, the Israeli Innovation Authority supported DALI with a special grant. The SAN-L product was given this grant for offering innovation and unique technology in the field of drug delivery devices.
